NCT07125170 Immersive Virtual Reality in Cognitive Rehabilitation of Patients With Post-Stroke Cognitive Impairment
| NCT ID | NCT07125170 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chile |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-06 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-08-06 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study aims to evaluate the feasibility of implementing immersive virtual reality (VR) in cognitive rehabilitation for adults with post-stroke cognitive impairment receiving outpatient therapy. Participants will use a head-mounted display and interactive software to engage in gamified cognitive exercises that simulate memory, attention, and executive function tasks. The intervention consists of 10 sessions, delivered two to three times per week over a period of approximately four weeks. The study will assess multiple feasibility indicators, including the recruitment rate based on eligibility criteria, the safety and tolerability of VR sessions for participants, and the usability and satisfaction reported by occupational therapists administering the intervention. Additionally, exploratory outcomes include changes in global cognition and specific cognitive domains, as well as self-reported quality of life. Adverse effects related to VR use will be tracked. This pilot study will help inform the design and implementation of future, larger-scale clinical trials.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age * Patients with a cerebrovascular accident of any etiology with less than 3 months of progression * Patients with mild to moderate cognitive impairment post-stroke (impairment in at least one cognitive domain) * MoCA score of less than 24 points * Referred for cognitive rehabilitation at the Occupational Therapy Unit of HCUCH Exclusion Criteria: * Patients with refractive errors that prevent the use of the headset * Patients with any type of aphasia that prevents the administration of the MoCA test * Patients with severe psychiatric disorders (presence of psychotic symptoms or derealization) * Patients with severe motor impairments (lack of trunk control or global strength of both upper limbs \< M3)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07125170 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07125170 currently recruiting?
Yes, NCT07125170 is actively recruiting participants. Contact the research team at ngattini@hcuch.cl for enrollment information.
Where is the NCT07125170 trial being conducted?
This trial is being conducted at Independencia, Chile.
Who is sponsoring the NCT07125170 clinical trial?
NCT07125170 is sponsored by University of Chile. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.